Print Get Citation Citation AMA Citation England J, Daud A. England J, Daud A England, James, and Anees Daud. "Soft drink consumption linked with increased all-cause mortality." 2 Minute Medicine, 16 September 2019. McGraw-Hill, New York, NY, 2019. AccessPediatrics. http://accesspediatrics.mhmedical.com/updatesContent.aspx?gbosid=500020§ionid=227477064 MLA Citation England J, Daud A. England J, Daud A England, James, and Anees Daud.. "Soft drink consumption linked with increased all-cause mortality." 2 Minute Medicine New York, NY: McGraw-Hill, 2019, http://accesspediatrics.mhmedical.com/updatesContent.aspx?gbosid=500020§ionid=227477064. Download citation file: RIS (Zotero) EndNote BibTex Medlars ProCite RefWorks Reference Manager Mendeley © Copyright Clip Full Chapter Figures Only Tables Only Videos Only Supplementary Content Top Soft drink consumption linked with increased all-cause mortality by James England, MD; Anees Daud, MD Listen +Originally published by 2 Minute Medicine® (view original article). Reused on AccessMedicine with permission. +1. In this population-based cohort study, consumption of total, sugar-, and artificially-sweetened soft drinks was linked with an increased risk of all-cause mortality. +2. The consumption of artificially-sweetened soft drinks was also linked to an increase in death from circulatory diseases. Sugar-sweetened soft drinks intake was associated with death from digestive diseases. +Evidence Rating Level: 1 (Excellent) Study Rundown: + +The frequent consumption of soft drinks has been linked to an increase risk of obesity, metabolic disease including diabetes, and cardiovascular disease. The current study sought to evaluate the mortality-risk related to consumption of both artificially- and sugar-sweetened soft drinks in a population from 10 European countries. The study found that there was an increase in all-cause mortality with frequency of any soft drinks, specifically with sugar-sweetened, and artificially-sweetened soft drinks. The consumption of sugar-sweetened drinks was linked with an increase of digestive disease-related death, while artificially-sweetened soft drinks was associated with death from circulatory disease. +The study provides further evidence that population health initiatives aimed at reduction of soft drink consumption may lead to decreased morbidity and mortality. The study strengths include the long-follow up of a large, diverse European population. The main limitation is the observational design which precludes the ability to attribute causality to the observed associations. +Click to read the study in JAMA Internal Medicine +Relevant Reading: Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: a systematic review and meta‐analysis In-Depth [prospective cohort]: + +This study is a population cohort involving adults from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. This study included participants from 10 European countries: (Denmark, France, Germany, Greece, Italy, the Netherlands, Norway, Spain, Sweden, and the United Kingdom. Participants were recruited between 1992 and 2000. Participants were excluded if they had a baseline history of cancer, heart disease, stroke, were in the highest or lowest 1% of energy intake, were missing data on soft drink consumption, or had missing follow-up data. Dietary information was determined using self-administered questionnaires or personal interviews. +A total of 451,743 participants were included in the study, with a median age of 50.8 years, and mean (range) follow-up of 16.4 years. Compared to non-consumers (<1 glass/month) those who consumed 2 or more glasses/day of soft drinks had higher all-cause mortality (hazard ratio [HR], 1.17; 95%CI, 1.11-1.22; P < .001). Sugar-sweetened soft drinks also had increased all cause (HR, 1.08; 95%CI, 1.01-1.16; P = .004) and digestive disease related mortality (HR, 1.59; 95%CI, 1.24-2.05; P < .001). Artificially sweetened soft drinks were linked with greater all-cause (HR, 1.26; 95%CI, 1.16-1.35; P < .001) and circulatory disease mortality (HR, 1.52; 95%CI, 1.30-1.78; P < .001) +©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.